Increased Toll-like Receptor-2 Expression on Nonclassic CD16+Monocytes from Patients with Inflammatory Stage of Eales' Disease

Aditi Sen, Imran Hussain Chowdhury, Debanjan Mukhopadhyay, Suman Kalyan Paine, Amrita Mukherjee, Lakshmi Kanta Mondal, Mitali Chatterjee, Basudev Bhattacharya
2011 Investigative Ophthalmology and Visual Science  
PURPOSE. To identify the distribution, differential Toll-like receptor (TLR) expression, and functional contribution of monocyte subpopulations in the inflammatory stage of Eales' disease (ED). METHODS. Peripheral blood mononuclear cells were isolated from nine patients during the inflammatory stage of ED and nine age-and sex-matched healthy controls. The expression of CD14, CD16, TLR-2, and TLR-4 on monocytes was measured by flow cytometry. The CD14 ϩ , CD16 Ϫ , and CD16 ϩ monocyte populations
more » ... were sorted on the basis of magnetic-activated cell-sorting methodology, and levels of cytokines were measured by ELISA. RESULTS. In ED patients, the number of circulating monocytes was significantly expanded compared with that in controls (P ϭ 0.01), with a marked increase in the nonclassic CD16 ϩ subset, which showed an activated phenotype in patients that correlated with levels of serum proinflammatory cytokines and clinical progression. A higher expression of cell surface TLR-2 (P ϭ 0.02), but not TLR-4, was found in monocytes of patients with ED. Furthermore, TLR-2 was expressed at higher levels on CD16 ϩ monocytes than on CD16 Ϫ monocytes in patients, whereas no significant variation was found in TLR-4 expression on different monocyte subsets. Peptidoglycan-induced TNF-␣ expression correlated with TLR-2 expression in monocytes isolated from controls (r ϭ 0.85, P ϭ 0.0061), but not in monocytes isolated from ED patients (r ϭ 0.553, P ϭ 0.1328). CONCLUSIONS. These results indicate that in the pathogenesis of ED, TLR activation and increased numbers of nonclassic CD16 ϩ monocytes are crucial regulators, along with the secretion of proinflammatory cytokines that perpetuate the inflammatory process in the retina. (Invest Ophthalmol Vis Sci. 2011; 52:6940 -6948)
doi:10.1167/iovs.11-7834 pmid:21791592 fatcat:dopx2up6izfnpbiymfgjaczufe